CHICAGO--(BUSINESS WIRE)-- Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the company is developing its ...

Shareef A. Nahas brings deep expertise in genomics and laboratory operations, with senior leadership experience at Rady Children’s Institute for Genomic Medicine, Genoptix (Novartis), and Ambry ...

GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced ultraRapid Whole Genome Sequencing, offering ...

A combined whole-genome sequencing approach could be used to detect and monitor cancer from liquid biopsies. It is challenging to monitor cancer from liquid biopsies due to the low concentrations of ...

Despite rapid advances in genome and exome sequencing, many individuals with rare diseases remain undiagnosed. In a Perspective article published in Nature Genetics, researchers at Karolinska ...

BEVERLY, Mass.--(BUSINESS WIRE)--seqWell, a global provider of genomic library and multiplexing workflow solutions, today announced the launch of AgriPrep™ Library Prep Kit, the newest addition to its ...

Whole-genome sequencing (WGS) has emerged as a widely applied tool in germline analyses, such as hereditary disease diagnostics and pharmacogenomics. As WGS increasingly transitions from research to ...

Whole-genome sequencing (WGS) has revolutionized the field of genomics, enabling scientists to explore the complete genetic makeup of individuals with unprecedented detail. By providing a ...

Whole genome sequencing (WGS) is not necessarily a solution for someone with a rare, monogenic disease. Indeed, more than half of families with suspected rare monogenic diseases do not have an answer ...

The market for whole genome and exome sequencing is set to grow significantly, driven by decreasing sequencing costs and a shift toward precision medicine. Opportunities lie in enhancing genomic ...